Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited

4502

Classifica tra le azioni #377
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Prezzo delle azioni
$40.31
Capitalizzazione di mercato
$64.13B
Variazione (1 giorno)
0.82%
Variazione (1 anno)
42.59%
Paese
JP
Scambia Takeda Pharmaceutical Company Limited (4502)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per Takeda Pharmaceutical Company Limited (4502)
L’azione Takeda Pharmaceutical Company Limited (simbolo: 4502) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Oct 22, 2026.
Una quota di 4502 acquistata prima di Oct 22, 2026 equivale oggi a 0 quote di 4502.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti